Search En menu en ClientConnect
Search
Results
Top 5 search results See all results Advanced search
Top searches
Most visited pages
    Reference: 20200610
    Release date: 2 January 2023

    Promoter – Financial Intermediary

    BRAINLAB AG

    Location

    Description

    The project will finance the promoter's research and development (R&D) activities within software-based technology and hardware medical devices aiming to improve critical surgeries, radiosurgery treatments and operating room efficiency.

    Additionality and Impact

    The project concerns the promoter's Research Development and Innovation (RDI) activities in Europe in Surgery, Radiosurgery and as of recent, Digital Health - in particular directed at digitalisation within the operating room. By financing this project, the Bank will support a technologically leading globally operating European-based medtech company specialised in software and hardware directed at medical technology and digital solutions in Health.


    This Project would further aid to accelerate adoption of digital technologies in the EU, related to R&D, healthcare and digital innovation while improving treatment outcomes. As such, through the financing of this Project aiming to facilitate increased investments in digital innovation the EIB is helping to bridge the digital gap between EU and US, e.g., and the digital divide within EU.


    Overall, the financing through the EIB will complement other financing sources and improve its credit risk profile by extending the debt maturity profile. EIB's favourable customised terms are highly appreciated by the company. Therefore, the loan is expected to provide a positive signalling effect in the market and crowd in complementary financing sources.

    Objectives

    By financing this project, the EIB will support a technologically leading globally operating European AI-based Digital Health company specialised in software and hardware for medical technology, directed at medical solutions in Health.

    Sector(s)

    Proposed EIB finance (Approximate amount)

    EUR 50 million

    Total cost (Approximate amount)

    EUR 154 million

    Environmental aspects

    The project investments concern research and development activities carried out in existing facilities without changing their already authorized scope, and are not expected to have a significant environmental impact on the surroundings. The project activities neither fall under Annexes I nor II of the EU Environmental Impact Assessment (EIA) Directive 2011/92/EU amended by Directive 2014/52/EU. The promoter complies with all relevant regulations and recommendations related to its business.

    Procurement

    The Promoter has been assessed by the EIB as being a private company not operating in the utilities sector and not having a status of a contracting entity. Thus, it is not covered by the EU Public Procurement Directives. The Promoter's procurement procedures are in line with industry practice. The project would be mostly implemented by staff within the promoter's existing R&D organisation, so there will be limited procurement activity directly related to the project.

    Status

    Signed - 22/12/2022

    Milestone
    Under appraisal
    Approved
    Signed
    21 December 2022
    22 December 2022

    Disclaimer

    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
    They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Related tags

    Germany Industry